SGLT2 Inhibition and Hospitalizations in Patients with Chronic Kidney Disease

Predictors of Kidney Outcomes in C3 Glomerulopathy and Idiopathic Membranoproliferative Glomerulonephritis

Perceptions of Future Earnings Among Nephrology Fellows

SGLT2 Inhibitors and Risk of Urinary Tract Infections with Abnormal Genitourinary Pathology

Transition Practices in Pediatric and Adult Nephrology

Creatinine and Cystatin-Based Equations in People with Cancer

GLP1 Receptor Agonists and Kidney Outcomes

Anticoagulation and Fracture Risk in CKD Patients with Atrial Fibrillation

Comparing USRDS vs. National Death Index on Sudden Cardiac Death in Dialysis Patients

Association of Kidney Function with SGLT2 Inhibitor Discontinuation

Interview with 2024 CJASN Trainee of the Year – Second Place Awardee: Dr. Mohammad Azfar Qureshi

Interview with 2024 CJASN Trainee of the Year – First Place Awardee: Dr. Christine Limonte

Providers' Experiences Discussing Alternatives to Kidney Replacement Therapy with Patients

Editors Choice Articles: SGLT2 inhibitors in frailty, multimorbidity and polypharmacy; SGLT2 inhibitors and cardiovascular death; and mobile health technology in CKD management

Fellows' Perspectives on Parental Leave Policies and Family Planning

Editors' Choice Articles: Pediatric ESKD iron stores, Impact of hemodiafiltration and hemodialysis on β-2-microglobulin, and Novel instruments for dialysis modality awareness

Kidney Measures and Venous Thromboembolism

Participant Experience in the KPMP - Spanish Language

Participant Experience in the KPMP

Resveratrol in CKD